Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,518 across all filing types
Latest filing 2024-09-02 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
NEXT DAY DISCLOSURE RETURNS
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and details changes in issued shares, treasury shares, and share repurchases by CSPC Pharmaceutical Group Limited. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) related to disclosure of share changes and repurchases. The content includes detailed tables of share repurchases, prices, dates, and confirmations of compliance with exchange rules. There is no indication of this being a full financial report, earnings release, or management discussion. Instead, it is a regulatory disclosure about share transactions and repurchases. This fits the definition of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is POS with high confidence.
2024-09-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2024
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 August 2024. It details movements in issued shares, treasury shares, share options, and repurchases for cancellation. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share movement information for the issuer CSPC Pharmaceutical Group Limited. It does not contain financial statements, earnings data, or management discussion, nor is it an announcement of a report publication. It is a regulatory filing related to share capital movements and compliance with exchange listing rules. Therefore, it fits best under the category 'Regulatory Filings (RNS)' as a general regulatory announcement that does not fit other specific categories.
2024-09-02 English
NEXT DAY DISCLOSURE RETURNS
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares, treasury shares, share buybacks, and on-market sales of treasury shares. It references specific rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) concerning disclosure of share repurchases and changes in issued shares. The content includes detailed tables of share repurchase transactions, prices, and confirmations of compliance with exchange rules. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is a regulatory disclosure about share repurchase activity and changes in capital structure. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement of a report publication or a certification. Therefore, the correct classification is POS with high confidence.
2024-08-30 English
NEXT DAY DISCLOSURE RETURNS
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares, treasury shares, share buybacks, and on-market sales of treasury shares. It references specific rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) governing disclosures of share repurchases and changes in issued shares. The content includes detailed tables of share repurchase transactions, dates, prices, and confirmations of compliance with exchange rules. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is a regulatory disclosure about share repurchase activities and changes in share capital. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares.
2024-08-29 English
VOLUNTARY ANNOUNCEMENT - DEXRAZOXANE FOR INJECTION OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by the board of directors of CSPC Pharmaceutical Group Limited regarding the approval of a drug product (Dexrazoxane for Injection) by the National Medical Products Administration of China. It does not contain financial data, financial results, or detailed report content. It is an announcement of a regulatory approval event related to the company's product portfolio, not a financial report, management change, or shareholder meeting material. The document is short (2004 characters) and serves as a public announcement of a significant corporate event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-28 English
NEXT DAY DISCLOSURE RETURNS
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares, treasury shares, share buybacks, and on-market sales of treasury shares. It references specific rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) concerning disclosure of share repurchases and changes in issued shares. The content includes detailed tables of share repurchase transactions, dates, prices, and confirmations of compliance with exchange rules. This is a regulatory disclosure about share repurchase activity and changes in capital structure, not a full financial report or earnings release. It fits the category of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares.
2024-08-28 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.